Cargando…
Noncoding RNAs Emerging as Drugs or Drug Targets: Their Chemical Modification, Bio-Conjugation and Intracellular Regulation
With the increasing understanding of various disease-related noncoding RNAs, ncRNAs are emerging as novel drugs and drug targets. Nucleic acid drugs based on different types of noncoding RNAs have been designed and tested. Chemical modification has been applied to noncoding RNAs such as siRNA or miR...
Autores principales: | Wang, Jin, Tian, Tian, Li, Xin, Zhang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573214/ https://www.ncbi.nlm.nih.gov/pubmed/36235253 http://dx.doi.org/10.3390/molecules27196717 |
Ejemplares similares
-
Noncoding RNAs in cancer therapy resistance and targeted drug development
por: Wang, Wen-Tao, et al.
Publicado: (2019) -
Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer
por: Wei, Ling, et al.
Publicado: (2023) -
The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma
por: Wei, Ling, et al.
Publicado: (2019) -
Long Noncoding RNAs-Related Diseases, Cancers, and Drugs
por: Tang, Jen-Yang, et al.
Publicado: (2013) -
Chemical Conjugation in Drug Delivery Systems
por: Eras, Alexis, et al.
Publicado: (2022)